Dudediligence.

AbbVie Inc

ABBVNYSE · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$21.7M

5 notices · 91,989 sh

Oct 2025 to Oct 2026

Reported ·

$10.7M

5 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

4 of 5 reported sales carry the 10b5-1 box. Together they are under 0.01% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-14: NICHOLAS DONOGHOE, Form 1442026-05-26: ROBERT J ALPERN, Form 1442026-03-04: David R. Purdue, Form 1442026-03-02: PERRY C SIATIS, Form 1442026-02-25: PERRY C SIATIS, Form 1442026-02-25: Siatis Perry C, sold2026-03-02: Siatis Perry C, sold2026-03-04: Purdue David Ryan, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-08-14NICHOLAS DONOGHOE, EVP, CHIEF BUS/STRAT OFFICER$8,177,500
32,710 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-26ROBERT J ALPERN, Director$2,781,991
13,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-03-04David R. Purdue, SVP, Controller$1,221,519
5,230 shno plan date144 ↗
Form 4, 2026-03-06: sold 5,230 at $233.56 Form 4 ↗
2026-03-02PERRY C SIATIS, EVP, GC AND SECRETARY$4,375,585
18,668 shplan 2025-11-18144 ↗
Form 4, 2026-03-03: sold 18,668 at $234.39 Form 4 ↗
2026-02-25PERRY C SIATIS, EVP, GC AND SECRETARY$5,147,630
22,381 shplan 2025-11-18144 ↗
Form 4, 2026-02-27: sold 22,381 at $230.00 Form 4 ↗